Antitumor effects of antibody enzyme conjugates in combination with prodrugs.
Senter
P D
PD
Oncogen, Seattle, Wash.
D000469:Alkaline Phosphatase / Q000627:therapeutic use*; D000818:Animals; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002417:Cattle; D003110:Colonic Neoplasms / Q000188:drug therapy; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D000922:Immunotoxins / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000188:drug therapy; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use; D009943:Organophosphorus Compounds; D011355:Prodrugs / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000922:Immunotoxins; D008937:Mitomycins; D009943:Organophosphorus Compounds; D011355:Prodrugs; C061399:mitomycin phosphate; C061400:etoposide phosphate; D005047:Etoposide; D000469:Alkaline Phosphatase